Mandal, Rajarsi <br/><br/>
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.  [electronic resource] 

 -  Science (New York, N.Y.)  05 2019 
 - 485-491 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.aau0447  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--therapeutic use<br/>DNA Mismatch Repair--genetics<br/>Genetic Variation<br/>Immunotherapy--methods<br/>Melanoma, Experimental--genetics<br/>Mice<br/>Microsatellite Instability<br/>MutS Homolog 2 Protein--genetics<br/>Mutation<br/>Neoplasms--genetics<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Treatment Outcome